Concepedia

Jan Rahnenführer

JR

Statistics

Publications

8

Citations

277

H-Index

8

Active since

2011

Affiliations

University of Potsdam(Current)

Charité - Universitätsmedizin Berlin

Hunan Normal University

Freie Universität Berlin

Boehringer Ingelheim (Germany)

Jan Rahnenführer is an author at University of Potsdam specializing in medicine, pharmacology, and medical genetics.

Publications per year

2011–2022

8

Publications

8

The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy

Oleg Tsuprykov, Ryotaro Ando, Christoph Reichetzeder et al. · Kidney International · 2016 · 91 citations · Full text

, , +17

Effects of DPP-4 Inhibitors on the Heart in a Rat Model of Uremic Cardiomyopathy

Lyubov Chaykovska, Karoline von Websky, Jan Rahnenführer et al. · PLoS ONE · 2011 · 81 citations · Full text

, , +11

Maternal eNOS deficiency determines a fatty liver phenotype of the offspring in a sex dependent manner

Berthold Hocher, Hannah Haumann, Jan Rahnenführer et al. · Epigenetics · 2016 · 23 citations · Full text

, , +16

Renal Effects of the Novel Selective Adenosine A1 Receptor Blocker SLV329 in Experimental Liver Cirrhosis in Rats

Berthold Hocher, Susi Heiden, Karoline von Websky et al. · PLoS ONE · 2011 · 19 citations · Full text

, , +17

Relaxin-2 Does Not Ameliorate Nephropathy in an Experimental Model of Type-1 Diabetes

Thomas Dschietzig, Katharina Krause-Relle, Maud Hennequin et al. · Kidney & Blood Pressure Research · 2015 · 19 citations · Full text

, , +16

1–5 of 8